Body

Sugar-sweetened drinks associated with higher blood pressure

Soda and other sugar-sweetened beverages such as fruit drinks are associated with higher blood pressure levels in adults, researchers report in Hypertension: Journal of the American Heart Association.

Researchers reformulate tenofovir vaginal gel for rectal use

BOSTON, Feb. 28, 2011 – A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests research presented today at the 18th Conference on Retroviruses and Opportunistic Infections (CROI). In laboratory tests of rectal tissue, researchers from the Microbicide Trials Network (MTN) found the reformulated gel was less harmful to the lining of the rectum than the original vaginal formulation, and just as effective in protecting cells against HIV.

High-cost hospitals do not appear to have better survival rates for sepsis patients

Increased hospital spending at high-cost hospitals does not appear to be associated with better short-term survival rates for patients with sepsis, according to a report in the February 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Older patients concerned about adverse effects of beneficial medications for CVD prevention

Older patients are willing to take medications for cardiovascular disease prevention, but only if the drug has much more benefit than risk, according to a report published online first by the Archives of Internal Medicine, one of the JAMA/Archives journals. The paper will be published in the June 27, 2011 print issue of the journal.

Low health literacy associated with greater variability in following prescription drug instructions

Many patients, especially those with limited literacy, may self-administer prescription medications more times a day than is necessary, which may lead to missed or incorrectly administered dosing, according to a report in the February 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Fear of side effects shapes older patients' willingness to take heart medication

Faced with the risk of developing side effects, even ones as mild as fatigue, nausea and fuzzy thinking, many older patients are willing to forego medications that provide only average benefit in preventing heart attack, according to a report by Yale School of Medicine researchers.

Gut bacteria can control organ functions

Bacteria in the human gut may not just be helping digest food but also could be exerting some level of control over the metabolic functions of other organs, like the liver, according to research published this week in the online journal mBio®. These findings offer new understanding of the symbiotic relationship between humans and their gut microbes and how changes to the microbiota can impact overall health.

Research opens door to vaccines that can circumvent maternal antibodies

COLUMBUS, Ohio – New research that reveals how maternal antibodies block an immune response to the measles virus is a first step toward improving current childhood vaccination practices, scientists say.

IDIBELL researchers discover a substance against the 'dark genome' of cancer

A research study coordinated by Manel Esteller, researcher at Bellvitge Biomedical Research Institute (IDIBELL) has identified a substance that inhibits cancer growth by activating the so‑called "dark genome" (or non‑coding DNA) and micro‑RNA molecules. The study appears this week in the journal Proceedings of the National Academy of Sciences (PNAS).

Development team achieves 1 terabit per second data rate on a single integrated photonic chip

WASHINGTON, Feb. 28—With worldwide Internet data traffic increasing by 50 percent each year, telecommunications companies that handle this digital torrent must be able to economically expand the capacities of their networks while also adapting to new, more-efficient data-handling technologies. Over the last decade, a development team at Infinera Corp. in Sunnyvale, Calif. has pioneered the design and manufacture of photonic integrated circuits (PICs) aimed at meeting that need.

Researchers develop curious snapshot of powerful retinal pigment and its partners

BETHESDA, Md., Feb. 28, 2011 – Science fiction novelist and scholar Issac Asimov once said, "The most exciting phrase to hear in science, the one that heralds new discoveries, is not 'Eureka!' but 'That's funny.' " This recently rang true for an international team of researchers when they observed something they did not expect.

Human stem cells from fat tissue fuse with rat heart cells and beat

If Dr. Doolittle is famous for talking to animals, then here's a story that might make him hold his tongue: According to new research published online in The FASEB Journal (http://www.fasebj.org), scientists have successfully fused human stem cells derived from subcutaneous adipose (fat) tissue with muscle cells from rat hearts. Not only did these cells "talk" to form new muscle cells altogether, but they actually beat.

Gay rights movement born in 19th century Germany, scholar says

Same-sex erotic relationships are as old as humanity, but our modern understanding of what it means to be homosexual—and the earliest gay rights movement—started in nineteenth-century Germany, according to an article by historian Robert Beachy from Goucher College.

The article, "The German Invention of Homosexuality," is published in a recent issue of The Journal of Modern History. Beachy's book on the subject, Gay Berlin: Birthplace of a Modern Identity (Knopf), is due out next year.

New marker found for Sanfilippo disease

Sanfilippo disease is a rare disorder caused by the failure of enzymes to break down specific kinds of complex carbohydrates, resulting in their accumulation in cells and often severe physical and neurological problems – and sometimes early death.

WSU researcher creates patented personalized therapy that causes cancer cells to kill themselves

A Wayne State University School of Medicine physician-researcher has developed a personalized therapy to treat a wide range of cancers. The treatment is based on a naturally occurring human enzyme that has been genetically modified to fool cancer cells into killing themselves.